138 related articles for article (PubMed ID: 9593221)
41. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
42. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
Sharara AI
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
[TBL] [Abstract][Full Text] [Related]
43. Effects of acute pancreatitis on hepatic secretion of lysosomal enzymes into bile and hepatic lysosomal fragility: protective effects of a new synthetic protease inhibitor, ONO 3307.
Hirano T; Manabe T; Calne R; Tobe T
Scand J Gastroenterol; 1992; 27(3):227-32. PubMed ID: 1502486
[TBL] [Abstract][Full Text] [Related]
44. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
Nishioka K; Nagao T; Urushidani T
Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
[TBL] [Abstract][Full Text] [Related]
45. Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Hishida A; Ohashi K; Ishizaki T
Clin Pharmacol Ther; 2005 Apr; 77(4):302-11. PubMed ID: 15903128
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
47. Rabeprazole.
Prakash A; Faulds D
Drugs; 1998 Feb; 55(2):261-7; discussion 268. PubMed ID: 9506245
[TBL] [Abstract][Full Text] [Related]
48. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
49. Bile reflux due to disturbed gastric movement is a cause of spontaneous gastric ulcer in W/Wv mice.
Azuma T; Dojyo M; Ito S; Yamazaki Y; Miyaji H; Ito Y; Suto H; Kuriyama M; Kato T; Kohli Y
Dig Dis Sci; 1999 Jun; 44(6):1177-83. PubMed ID: 10389693
[TBL] [Abstract][Full Text] [Related]
50. [The effect of proton pump inhibitor on intragastric acidity and it relation to S-mephenytoin hydroxylase genetic polymorphism].
Wang H; Nie YQ; Dai SJ; She QZ; Li YY
Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):777-80. PubMed ID: 14636465
[TBL] [Abstract][Full Text] [Related]
51. Influence of acute injection of chloroquine on the biliary secretion of lipids and lysosomal enzyme on rats.
Lafont H; Chanussot F; Dupuy C; Lechene P; Lairon D; Charbonnier-Augeire M; Chabert C; Portugal H; Pauli AM; Hauton JC
Lipids; 1984 Mar; 19(3):195-201. PubMed ID: 6717251
[TBL] [Abstract][Full Text] [Related]
52. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
53. Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders.
Skoczylas T; Sarosiek I; Sostarich S; McElhinney C; Durham S; Sarosiek J
Dig Dis Sci; 2003 Feb; 48(2):322-8. PubMed ID: 12643610
[TBL] [Abstract][Full Text] [Related]
54. Coordinate secretion of acid hydrolases in rat bile.
LaRusso NF; Fowler S
J Clin Invest; 1979 Oct; 64(4):948-54. PubMed ID: 113427
[TBL] [Abstract][Full Text] [Related]
55. Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.
Park JB; Imamura L; Kobashi K
Biol Pharm Bull; 1996 Feb; 19(2):182-7. PubMed ID: 8850302
[TBL] [Abstract][Full Text] [Related]
56. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
Masubuchi N; Hakusui H; Okazaki O
Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
[TBL] [Abstract][Full Text] [Related]
57. Circadian rhythms of biliary protein and lipid excretion in rats.
Nakano A; Tietz PS; LaRusso NF
Am J Physiol; 1990 May; 258(5 Pt 1):G653-9. PubMed ID: 2159238
[TBL] [Abstract][Full Text] [Related]
58. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
Langtry HD; Markham A
Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
[TBL] [Abstract][Full Text] [Related]
59. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
[TBL] [Abstract][Full Text] [Related]
60. A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
Ando T; Kato H; Sugimoto N; Nagao Y; Seto N; Hongo H; Kajikawa H; Isozaki Y; Shimozawa M; Naito Y; Yoshida N; Ishizaki T; Yoshikawa T
Dig Dis Sci; 2005 Sep; 50(9):1625-31. PubMed ID: 16133961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
